Abstract:The recent technical and computational advances in single-cell sequencing technologies have significantly broaden our toolkit to study tumor microenvironment (TME) directly from human specimens. The TME is the complex and dynamic ecosystem composed of multiple cell types, including tumor cells, immune cells, stromal cells, endothelial cells, and other non-cellular components such as the extracellular matrix and secreted signaling molecules. The great success on immune checkpoint blockade therapy has highlighted the importance of TME on anti-tumor immunity and has made it a prime target for further immunotherapy strategies. Applications of single-cell transcriptomics on studying TME has yielded unprecedented resolution of the cellular and molecular complexity of the TME, accelerating our understanding of the heterogeneity, plasticity, and complex cross-interaction between different cell types within the TME. In this review, we discuss the recent advances by single-cell sequencing on understanding the diversity of TME and its functional impact on tumor progression and immunotherapy response driven by single-cell sequencing. We primarily focus on the major immune cell types infiltrated in the human TME, including T cells, dendritic cells, and macrophages. We further discuss the limitations of the existing methodologies and the prospects on future studies utilizing single-cell multi-omics technologies. Since immune cells undergo continuous activation and differentiation within the TME in response to various environmental cues, we highlight the importance of integrating multimodal datasets to enable retrospective lineage tracing and epigenetic profiling of the tumor infiltrating immune cells. These novel technologies enable better characterization of the developmental lineages and differentiation states that are critical for the understanding of the underlying mechanisms driving the functional diversity of immune cells within the TME. We envision that with the continued accumulation of single-cell omics datasets, single-cell sequencing will become an indispensable aspect of the immune-oncology experimental toolkit. It will continue to drive the scientific innovations in precision immunotherapy and will be ultimately adopted by routine clinical practice in the foreseeable future.

Deciphering Tumor-Infiltrating Dendritic Cells in the Single-Cell Era

Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level

Unravelling the Heterogeneity and Dynamic Relationships of Tumor-Infiltrating T Cells by Single-Cell RNA Sequencing Analysis

Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells

Dendritic cell subsets and implications for cancer immunotherapy

Dendritic cell biology and its role in tumor immunotherapy

Applications of Single-Cell Omics to Dissect Tumor Microenvironment

Dendritic cell subsets in cancer immunity and tumor antigen sensing

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications

Dendritic cells as orchestrators of anticancer immunity and immunotherapy

Impaired function of dendritic cells within the tumor microenvironment

Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance

The role of dendritic cells in cancer immunity and therapeutic strategies

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment

T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution

Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing

Advances in Research of Tumor Infiltrating Dentritic Cells

Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Single-Cell Informatics for Tumor Microenvironment and Immunotherapy

Extensive exploration of T cell heterogeneity in cancers by single cell sequencing.